Synthesis of active-site rich molybdenum-doped manganese tungstate nanocubes for effective electrochemical sensing of the antiviral drug (COVID-19) nitazoxanide

Ramaraj Sukanya,Sonaimuthu Mohandoss,Yong Rok Lee

DOI: https://doi.org/10.1016/j.chemosphere.2022.137005

IF: 8.8

2022-11-16

Chemosphere

Abstract:Nitazoxanide (NTZ), a promising antiviral agent, is currently being tested in clinical trials as a potential treatment for novel coronavirus disease 2019 (COVID -19). This paper describes a one-pot hydrothermal synthesis to prepare molybdenum (Mo)-doped manganese tungstate nanocubes (Mo–MnWO 4 NCs) for the electrochemical sensing of NTZ. The as-prepared Mo–MnWO 4 NCs were characterized using various techniques such as XRD, Raman, FE-SEM, FE-TEM, and XPS to confirm the crystal structure, morphology, and elemental composition. The obtained results demonstrate that Mo doping on MnWO 4 generates many vacancy sites, exhibiting remarkable electrochemical activity. The kinetic parameters of the electrode modified with Mo–MnWO 4 NCs were calculated to be (Ks) 1.1 × 10 −2 cm 2 s −1 and (α) 0.97, respectively. Moreover, a novel electrochemical sensor using Mo–MnWO 4 NCs was fabricated to detect NTZ, which is used as a primary antibiotic to control COVID-19. Under optimal conditions, the electrochemical reduction of NTZ was determined with a low detection limit of 3.7 nM for a linear range of 0.014–170.2 μM with a high sensitivity of 0.78 μA μM −1 cm −2 and negligible interference with other nitro group-containing drugs, cations, and anions. The electrochemical sensor was successfully used to detect NTZ in the blood serum and urine samples and achieved high recoveries in the range of 94–99.2% and 95.3–99.6%, respectively. This work opens a way to develop high-performance sensing materials by exploring the introduction of defect engineering on metal tungstates to detect drug molecules for practical applications.

environmental sciences